MRNY
YieldMax MRNA Option Income Strategy ETF
MRNY
Closed
$20.00
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNY was created on 2023-10-23 by YieldMax. The fund's investment portfolio concentrates primarily on health care equity. MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
Company
YieldMax
Asset class
Equity
Inception date
2023
Investment segment
Health Care
ISIN
US88636X2036
Website
Key stats
Open
$19.84
Volume
233.01K
AUM
$136.67M
Prev. close
$19.84
Expense ratio
1.00%
P/E
0.00
$19.84
Day’s Range
$20.39
$14.50
52W Range
$23.38
What’s in the fund
30
Total holdings
MRNA US 07/17/26 C50
41.50%
United States Treasury Bills 0%
14.18%
United States Treasury Bills 0%
13.43%
United States Treasury Bills 0%
13.39%
United States Treasury Bills 0%
11.66%
United States Treasury Bills 0%
11.31%
Mrna 07/17/2026 50.01 C
4.87%
First American Government Obligs X
4.32%
MRNA US 07/02/26 C65
3.58%
Others
-18.24%
Returns
Performance
_
Difference
_
YieldMax MRNA Option Income Strategy ETF
Jul
6
Dividends
The last payment date was Jul 6, 2026
Div. per Share
$0.39
Div. Yield
1.99%
Div. Growth YoY
-87.20%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply